Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s innovative drug development initiative-Group 3 pulmonary hypertension

By sjmartinez • July 1, 2022

Nikkho SM, Richter MJ, Shen E, Abman SH, Antoniou K, Chung J, Fernandes P, Hassoun P, Lazarus HM, Olschewski H, Piccari L, Psotka M, Saggar R, Shlobin OA, Stockbridge N, Vitulo P, Vizza CD, Wort SJ, Nathan SD. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulm Circ. 2022 Jul 1;12(3):e12127. doi: 10.1002/pul2.12127. PMID: 36016668; PMCID: PMC9395696.

Tags: Epidemiology, interstitial lung disease, prognosis, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine, symptom assessment and management

Glomerular Structure and Function in Type 2 Diabetes Stratified by Glomerular Basement Membrane Thickening

Mottl AK, Ekinci EI, Basgen JM, Jennette JC, Hu Y, Hogan SL, Power D, Skene A, Nicholas SB, Mauer M. Glomerular Structure and Function in[...]

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

Tai D, Kim KI, Shah P, Park D, Kim L, Li J, Jung C, Guzman S, Brar G, Wu S, Castillo D. Impact of metastatic[...]

Area Deprivation Index Predicts Colonoscopic Follow-up After Abnormal Fecal Immunochemical Testing for Colorectal Cancer Screening

Arif Y, Thomson AE, Tuan JJ, Badiee J, May FP. Area Deprivation Index Predicts Colonoscopic Follow-up After Abnormal Fecal Immunochemical Testing for Colorectal Cancer Screening.[...]